PATENT CLAIM ANALYSIS

Application Number: 16183593
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.

Claim (Index 50):
The method of  claim 35 , wherein the nanoemulsion formulation administered to the eye of the subject further comprises a preservative.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.29412
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12007902', '14623150', '15142709', '15546205', '11363379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578966797431508
- 35 USC 102 Novelty (BERT): 0.5466091905501858
- Combined Prediction Score: 0.7367679308238543
- Mean Citation Score: 248.336942
- Max Citation Score: 435.34525
- Similarity Product: 254.43146221354604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test